PURPOSE: In 2005 a French multicentric non randomized prospective study was initiated to
compare two groups of patients treated for cervix carcinoma according to brachytherapy (BT) …

Aim: To investigate whether common terminology criteria for adverse events (CTCAE) grade
4 lymphopenia (< 200 cells/μl) during concurrent chemoradiotherapy (CCRT) is relevant to …

Purpose To evaluate the local control and toxicities of three-dimensional image-guided
combined intracavitary and interstitial (IC/IS) high-dose-rate brachytherapy (BT) in cervical …

Various quantitative and semi-quantitative imaging biomarkers have been identified that
may serve as valid surrogates for the risk of recurrence after radiotherapy. Tumour …

PURPOSE: To investigate pelvic insufficiency fractures (IF) after definitive pelvic radiation
therapy for early-stage uterine cervical cancer, by analyzing subjects of a prospective, multi …

Background In this study, high risk clinical target volumes (HR-CTVs) according to GEC-
ESTRO guideline were contoured retrospectively based on CT images taken at the time of …

Definitive radiotherapy for cervical cancer consists of external-beam radiotherapy (EBRT)
and brachytherapy. In EBRT, a central shield (CS) reduces the dose to the rectum and …

Objective: The study aimed to evaluate the incidence of early and late radiation enteritis in
cervical cancer patients receiving definitive or adjuvant radiotherapy (RT). Materials and …

Purpose To analyze the dose–volume histogram of the central shielding technique for
cervical cancer radiotherapy by computing the composite three-dimensional EQD2 dose …

Purpose In the management of cervical cancer with definitive radiation therapy,
brachytherapy plays a central role because it has intrinsic physical property of steep dose …